CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $414,640 | -12.9% | 71,000 | 0.0% | 0.15% | -21.9% |
| Q3 2022 | $476,000 | +64.1% | 71,000 | +2.9% | 0.19% | +68.4% |
| Q2 2022 | $290,000 | +87.1% | 69,000 | +50.0% | 0.11% | +132.7% |
| Q1 2022 | $155,000 | +6.9% | 46,000 | 0.0% | 0.05% | 0.0% |
| Q4 2021 | $145,000 | -3.3% | 46,000 | 0.0% | 0.05% | -31.9% |
| Q3 2021 | $150,000 | +2.7% | 46,000 | +33.3% | 0.07% | +26.3% |
| Q2 2021 | $146,000 | – | 34,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |